Loading…
CAPR
CAPRICOR THERAPEUTICS, INC.NasdaqResearch view
Healthcare · Pharmaceutical Preparations · SEC EDGAR FY 2025-12-31
Price history
Interactive · live data via TradingView🔒 Click to interact · scroll moves the page
Snapshot
SEC EDGAR · FY 2025-12-31SectorHealthcare
Income—
Sales$0
Book/sh$5.26
Cash/sh$4.95
Dividend TTM—
Payout—
Employees—
IPO—
Every figure here is filed with the SEC. Valuation and estimate metrics (P/E, PEG, EV/EBITDA, price targets, forward EPS) are omitted until our market-data feed is licensed for display — we’d rather show fewer numbers than blank ones. Deeper lines (cash flow, balance sheet) below.
Revenue & Earnings — fiscal year
$244,898
2021
$2.6M
2022
$25.2M
2023
$22.3M
2024
$0
2025
Financials — annual
SEC EDGAR · last 5 FY · tap a row to explain it| USD | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | $244,898 | $2.6M | $25.2M | $22.3M | $0 |
| Gross Profit | — | — | — | — | — |
| Operating Income | $-20.9M | $-29.7M | $-24.1M | $-42.6M | $-108.1M |
| Net Income | $-20.0M | $-29.0M | $-22.3M | $-40.5M | $-105.0M |
| Diluted EPS | $-0.87 | $-1.18 | $-0.83 | $-1.15 | $-2.26 |
| Operating Cash Flow | $-16.8M | $4.9M | $-25.6M | $-40.0M | $-69.8M |
| Free Cash Flow | $-18.0M | $2.9M | $-26.9M | $-41.2M | $-72.7M |
Deep dive
Computed from the SEC EDGAR multi-year statementsOperating leverage — margins
GrossOperatingNet
Follow the news. Follow the move.
CAPR story timeline
Company updates and connected market context, with the dated price move attached.
2
Stories
2
Direct
COMMUNITY · $CAPR0 theses
POST YOUR TAKE →Related Stocks
Loading peers…
Fundamentals sourced from SEC EDGAR filings (public domain). For informational purposes only. Not investment advice.